Collective Audience Inc
NASDAQ:CAUD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Collective Audience Inc
NASDAQ:CAUD
|
US |
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
M
|
Metallica Metals Corp
CNSX:MM
|
CA |
|
FiEE Inc
NASDAQ:FIEE
|
US |
|
XTC Lithium Ltd
OTC:XTCPF
|
AU |
|
A
|
AE Fuels Corp
OTC:NRGFF
|
CA |
|
S
|
Sino United Worldwide Consolidated Ltd
OTC:SUIC
|
US |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Crypto Co
OTC:CRCW
|
US |
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Anabuki Kosan Inc
TSE:8928
|
JP |
|
Y
|
York Space Systems Inc
NYSE:YSS
|
US |
|
C
|
China Fishery Group Ltd
SGX:B0Z
|
HK |
|
D
|
DigiMax Global Inc
OTC:DBKSF
|
CA |
Balance Sheet
Balance Sheet Decomposition
Collective Audience Inc
Collective Audience Inc
Balance Sheet
Collective Audience Inc
| Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
|
| Cash |
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
1
|
|
| Total Receivables |
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
|
| Total Current Assets |
0
|
1
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
5
|
|
| Goodwill |
0
|
0
|
6
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Long-Term Investments |
57
|
13
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
6
|
|
| Total Assets |
58
N/A
|
13
-77%
|
12
-9%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
3
|
|
| Accrued Liabilities |
1
|
2
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
5
|
|
| Long-Term Debt |
0
|
2
|
4
|
|
| Other Liabilities |
2
|
2
|
0
|
|
| Total Liabilities |
2
N/A
|
6
+174%
|
9
+45%
|
|
| Equity | ||||
| Common Stock |
52
|
13
|
0
|
|
| Retained Earnings |
1
|
6
|
40
|
|
| Additional Paid In Capital |
4
|
0
|
43
|
|
| Total Equity |
55
N/A
|
7
-87%
|
3
-59%
|
|
| Total Liabilities & Equity |
58
N/A
|
13
-77%
|
12
-9%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
7
|
3
|
14
|
|